Hepatic complications of oral contraceptive pills and estrogen on MRI: Controversies and update - Adenoma and beyond.

@article{Ponnatapura2019HepaticCO,
  title={Hepatic complications of oral contraceptive pills and estrogen on MRI: Controversies and update - Adenoma and beyond.},
  author={Janardhana Ponnatapura and Ania Z. Kielar and Lauren M. B. Burke and Mark E. Lockhart and Abdul Rahman Abualruz and Rafel R Tappouni and Neeraj Lalwani},
  journal={Magnetic resonance imaging},
  year={2019},
  volume={60},
  pages={
          110-121
        }
}
A systematic review on the complications and management of hepatic adenomas: a call for a new approach
TLDR
It is highlighted that tumour size and subtype may not be as characteristically linked with complications as previously thought, and the risk of taking a conservative approach to seemingly low-risk lesions is highlighted and revised practice guidelines are suggested.
Hepatic hemangiomas: the various imaging avatars and its mimickers
TLDR
The diverse imaging appearances of hemangiomas on the commonly used imaging modalities are reviewed with illustrations to provide a gamut of common and uncommonly encounteredhemangioma mimickers.
Mini-invasive treatment of hepatic hemangioma: new efforts for an uncommon task
TLDR
In this uncommon condition, the mini-invasive approach should play a relevant role, mainly in consideration of the fact that HH represents a benign condition, and a less invasive approach appears to be coherent in this field.
Hepatocrinology
TLDR
A perspective shares the definition, concept, and scope of hepatocrinology and shares insight related to this aspect of medicine and is hoped that this communication will encourage further attention and research in this critical field.
Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications.
TLDR
Depending on its unique imaging features including enhancement filling pattern, hyper-enhanced subcapsular artery and presence of washout, CEUS might provide helpful diagnostic information for preoperative prediction of various HCA molecular subtypes.
Approach to the Patient with Liver Disease
  • N. Bergasa
  • Medicine
    Clinical Cases in Hepatology
  • 2021
Invited Commentary on "Hyperintense Liver Masses at Hepatobiliary Phase Gadoxetic Acid-enhanced MRI".
  • N. Lalwani
  • Medicine
    Radiographics : a review publication of the Radiological Society of North America, Inc
  • 2019

References

SHOWING 1-10 OF 63 REFERENCES
Liver tumors in women on contraceptive steroids.
TLDR
Gynecologists are alerted to the fact that many of the patients present with symptoms of acute abdomen, syncope or shock, and intrahepatic or intraperitoneal bleeding, and prompt diagnosis and treatment may be lifesaving.
Sex hormones and hepatic neoplasia.
The recent increase in hepatocellular neoplasms in women of child-bearing age taking oral contraceptives and in individuals of both sexes taking anabolic androgenic steroids is a phenomenon that
Generalized peliosis hepatis and cirrhosis after long-term use of oral contraceptives.
TLDR
A 43-yr-old woman with generalized peliosis hepatis that developed during long-term use of oral contraceptives is diagnosed and underwent successfully an orthotopic liver transplantation.
Generalised peliosis hepatis mimicking metastases after long-term use of oral contraceptives.
TLDR
PH should be considered in the differential diagnosis of women with a long history of use of oral contraceptives with suspected hypervascular lesions diagnosed by imaging, but with an unknown primary tumour.
Hepatobiliary complications of oral contraceptives
TLDR
Women with current or previous benign or malignant hepatic tumors should not take oral contraceptives, and those with familial defects of biliary excretion, including the Dubin-Johnson syndrome, Rotor's syndrome, and benign intrahepatic recurrent cholestasis are recommended.
Hepatocellular Carcinoma in Women: Probable Lack of Etiologic Association with Oral Contraceptive Steroids
TLDR
The apparent increase in HCC in young women can be explained by the presence of cases of fibrolamellar carcinoma in this age group, and the apparent association with CS is probably coincidental.
Liver Hamartomas in Patients on Oral Contraceptives
TLDR
Three cases are reported of tumour-like lesions of the liver in women who had been on oral contraceptives for long periods, and the possibility of an association between liver hamartomas and oral contraceptive therapy has to be considered.
Liver tumors in women on contraceptive steroids.
TLDR
The diagnosis of bleeding from a liver tumor should be considered when a young woman patient has abdominal pain and shock or other evidence of an acute abdominal emergency, early diagnosis and treatment may be life-saving.
Oral contraceptives and liver hemangioma: a case‐control study
Objective.  To study whether there is an epidemiological association between liver hemangiomas and oral contraception use, as may be suggested by clinical observations of liver hemangioma growth
...
1
2
3
4
5
...